Isaac Odame | |
---|---|
Known for | World-Renowned Sickle Cell Disease Specialist [1] |
Scientific career | |
Fields | |
Institutions |
Isaac Odame is a Ghanaian academic and physician who specialises in sickle cell disease. [2] [3] He is a professor of Hematology and Oncology at the Paediatrics department of the University of Toronto. He holds the Alexandra Yeo Chair in Hematology at the University of Toronto. He is the Director of the Hematology Division of the university's Department of Medicine. He is a staff physician of The Hospital for Sick Children, where he serves as the medical director of the Global Sickle Cell Disease Network located at the Centre for Global Child Health. [4] [5] [6] He is a founder of the Global Sickle Cell Disease Network. [7] [8] [9] [10] [11]
Odame had his secondary education at the Accra Academy. He continued at the University of Ghana, where he graduated (MB BCh) in 1982. He obtained membership of the Royal College of Physicians in 1991. [12]
Odame moved to Canada in 2000 to further his work as a medical recruit of McMaster University. [13] After six years of service at the Health Sciences Centre in Hamilton, Odame joined the Hospital for Sick Children in Toronto. [14]
Odame is a member of the Royal College of Physicians, a fellow of the Royal College of Pathologists, a fellow of the Royal College of Paediatrics and Child Health, and a fellow of the Royal College of Physicians of Canada. [8]
Odame's research and clinical works are in the field of sickle cell disease, thalassemia and other hematological disorders. His work at the Centre for Global Child Health also focuses on creating a continuous partnership between clinicians and scientists globally to foster academic research and improve medical care especially in developing countries with the largest disease burden. [7] [8] [9] [10] [11]
Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. Such diseases might include hemophilia, sickle cell anemia, blood clots (thrombus), other bleeding disorders, and blood cancers such as leukemia, multiple myeloma, and lymphoma. The laboratory analysis of blood is frequently performed by a medical technologist or medical laboratory scientist.
The Hospital for Sick Children (HSC), corporately branded as SickKids, is a major pediatric teaching hospital located on University Avenue in Toronto, Ontario, Canada. Affiliated with the Faculty of Medicine of the University of Toronto, the hospital was ranked the top pediatric hospital in the world by Newsweek in 2021.
The Temerty Faculty of Medicine is the medical school of the University of Toronto. Founded in 1843, the faculty is based in Downtown Toronto and is one of Canada's oldest institutions of medical studies, being known for the discovery of insulin, stem cells and the site of the first single and double lung transplants in the world.
A children's hospital(CH) is a hospital that offers its services exclusively to infants, children, adolescents, and young adults from birth up to until age 18, and through age 21 and older in the United States. In certain special cases, they may also treat adults. The number of children's hospitals proliferated in the 20th century, as pediatric medical and surgical specialties separated from internal medicine and adult surgical specialties.
Yuet Wai Kan, is a Chinese-American geneticist and hematologist. He is the current Louis K. Diamond Chair in Hematology and a Professor Emeritus at the University of California, San Francisco. He is a former president of the American Society of Hematology.
Sickle cell disease (SCD), also simply called sickle cell, is a group of hemoglobin-related blood disorders that are typically inherited. The most common type is known as sickle cell anemia. Sickle cell anemia results in an abnormality in the oxygen-carrying protein haemoglobin found in red blood cells. This leads to the red blood cells adopting an abnormal sickle-like shape under certain circumstances; with this shape, they are unable to deform as they pass through capillaries, causing blockages. Problems in sickle cell disease typically begin around 5 to 6 months of age. A number of health problems may develop, such as attacks of pain in joints, anemia, swelling in the hands and feet, bacterial infections, dizziness and stroke. The probability of severe symptoms, including long-term pain, increases with age. Without treatment, people with SCD rarely reach adulthood but with good healthcare, median life expectancy is between 58 and 66 years. All of the major organs are affected by sickle cell disease. The liver, heart, kidneys, gallbladder, eyes, bones, and joints can be damaged from the abnormal functions of the sickle cells and their inability to effectively flow through the small blood vessels.
Carroll Lockard "Lock" Conley was a hematologist and founder of the Division of Hematology at the Johns Hopkins School of Medicine.
Adeyinka Gladys Falusi, FAS NPOM, is a Nigerian Professor of haematology and former Director of the Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan.
Graham Roger Serjeant is a British medical researcher who studied sickle-cell disease in Jamaica, setting up screening programmes and a cohort study from birth. He directed the MRC Laboratories at the University of the West Indies and instituted the Sickle Cell Trust (Jamaica), a local charity. He has written four books and approximately 500 papers on sickle-cell disease. His work addressed the variability of sickle-cell disease with special emphasis on developing low-cost models of management suitable to countries with large numbers of patients and limited resources.
Griffin P. Rodgers is the director of the National Institute of Diabetes and Digestive and Kidney Diseases, one of the 27 institutes that make up the United States National Institutes of Health. He is also the Chief of the institute's Molecular and Clinical Hematology Branch and is known for contributions to research and therapy for sickle cell anemia.
Felix Israel Domeno Konotey-Ahulu FGA, FRCPSG, FRCP, FWACP is a Ghanaian physician and scientist who is Kwegyir Aggrey Distinguished Professor of Human Genetics at the University of Cape Coast, Ghana, and a consultant physician/genetic counsellor, Haemoglobinopathy/Sickle Cell States, in Harley Street, London. He is one of the world's foremost experts on sickle-cell disease.
Yvette Francis-McBarnette was an American pediatrician and a pioneer in treating children with sickle cell anaemia.
Lisa Robinson is a Canadian clinician-scientist. She is a University of Toronto professor in the Department of Paediatrics and the Dean of the Temerty Faculty of Medicine, former Head of the Division of Nephrology at The Hospital for Sick Children, a Senior Scientist at the SickKids Research Institute, President American Pediatric Society 2022-2023, and the first-ever Chief Diversity officer for the Faculty of Medicine at University of Toronto.
Zulfiqar A. Bhutta is a physician. He holds titles across various organizations in diverse geographies. Professor Bhutta is the Founding Director of the Center of Excellence in Women and Child Health & Institute for Global Child Health & Development, at the Aga Khan University South-Central Asia, East Africa & United Kingdom.
Swee Lay Thein is a Malaysian haematologist and physician-scientist who is Senior Investigator at the National Institutes of Health. She works on the pathophysiology of haemoglobin disorders including sickle cell disease and thalassemia.
Alan M. Emond is a British paediatrician and professor emeritus in Child Health at Bristol Medical School at the University of Bristol. Emond is most notable for research into child and adolescent injury, epidemiology and health service evaluation as well as the Avon Longitudinal Study of Parents and Children.
Roland Boyd Scott was an American researcher, pediatrician and authority on sickle cell disease. Scott authored a key paper in 1948 describing the incidence of sickle cell in infants that eventually led to the establishment of routine screening for newborns. He established the Howard University Center for Sickle Cell Disease. He was chairman of the pediatrics department at Howard University. He lobbied Congress to pass the Sickle Cell Anemia Control Act of 1971. He authored over 250 academic publications on allergy, growth and development, and sickle cell disease.
Kwaku Ohene-Frempong was a Ghanaian pediatric hematologist-oncologist and an expert in sickle cell disease (SCD). Ohene-Frempong grew up in Ghana and was a standout athlete in track-and-field, later competing for Yale University as well as Ghana at the 1970 British Commonwealth Games. He continued his medical training in the United States, where he completed medical school, pediatrics residency and a pediatric hematology-oncology fellowship. With a professional interest in SCD, Ohene-Frempong was a physician and involved in public health initiatives at Tulane University School of Medicine in New Orleans, Louisiana, and later the Children's Hospital of Philadelphia (CHOP) in Pennsylvania. He continued professional relationships with Komfo Anokye Teaching Hospital in Kumasi, Ghana where he later became a full-time physician after retiring from CHOP. In Ghana, he established public health initiatives for SCD screening in newborns, as well as an SCD clinic for patients with the disease.
Julie Ann Panepinto is an American pediatric hematologist-oncologist and physician-scientist. She specializes in health outcomes research and sickle cell disease. Panepinto became the acting director of the division of blood diseases and resources at the National Heart, Lung, and Blood Institute in 2022. She was a professor of pediatrics and hematology at the Medical College of Wisconsin.
Irene Roberts is a British physician-scientist specializing in pediatric hematology. She is an emeritus professor of paediatric haematology at the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.